Shockwave Medical Inc (SWAV)
327.25
-0.25
(-0.08%)
USD |
NASDAQ |
Apr 18, 16:00
327.40
+0.15
(+0.05%)
After-Hours: 20:00
Shockwave Medical Cash from Operations (TTM): 196.05M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 196.05M |
September 30, 2023 | 176.79M |
June 30, 2023 | 160.62M |
March 31, 2023 | 149.76M |
December 31, 2022 | 117.73M |
September 30, 2022 | 86.13M |
June 30, 2022 | 60.96M |
March 31, 2022 | 34.28M |
December 31, 2021 | 15.04M |
September 30, 2021 | -18.19M |
June 30, 2021 | -43.95M |
Date | Value |
---|---|
March 31, 2021 | -64.30M |
December 31, 2020 | -71.18M |
September 30, 2020 | -71.36M |
June 30, 2020 | -65.53M |
March 31, 2020 | -57.88M |
December 31, 2019 | -48.11M |
September 30, 2019 | -45.35M |
June 30, 2019 | -44.63M |
March 31, 2019 | -44.50M |
December 31, 2018 | -41.46M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-71.36M
Minimum
Sep 2020
196.05M
Maximum
Dec 2023
24.57M
Average
-18.19M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Boston Scientific Corp | 2.503B |
AtriCure Inc | 4.484M |
Masimo Corp | 94.10M |
Perspective Therapeutics Inc | -36.91M |
Xtant Medical Holdings Inc | -9.515M |